Anderman Todd

Chief Legal Officer at OCUL

Sold, on record
$225k
Dollars the filings state
Form 4 sales
2
Latest Oct 8, 2026
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • OCULOCULAR THERAPEUTIX, INCChief Legal Officer

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice OCULNotice
    Oct 8, 2025 2025

    Filed to sell 11,132 shares ($137k)

    Anderman Todd, Officer

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale OCULRoutine
    Oct 8, 2025 same day

    Sold 11,132 shares at $12.34 ($137k)

    Anderman Todd, Chief Legal Officer

    10b5-1 planSold 11.3% of holdings ($1.2M position)87,568 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice OCULNotice
    Oct 8, 2026 +365 days

    Filed to sell 11,984 shares ($87k)

    Anderman Todd, Officer

    No 10b5-1 planFiling

  4. 4 Form 4 sale OCULRoutine
    Oct 8, 2026 same day

    Sold 11,984 shares at $7.29 ($87k)

    Anderman Todd, Chief Legal Officer

    10b5-1 planSold 7.9% of holdings ($1.1M position)140,484 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Anderman Todd
Source
Oct 8, 2026Oct 13, 2026OCULChief Legal OfficerForm 4 sale11,984$87k7.9%RoutineSEC
Oct 8, 2026Oct 8, 2026OCULOfficerForm 144 notice11,984$87kNoticeSEC
Oct 8, 2025Oct 10, 2025OCULChief Legal OfficerForm 4 sale11,132$137k11.3%RoutineSEC
Oct 8, 2025Oct 8, 2025OCULOfficerForm 144 notice11,132$137kNoticeSEC